Search Results - "Kojima, Yoh"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Oncolytic Gene Therapy Combined with Double Suicide Genes for Human Bile Duct Cancer in Nude Mouse Models by Kojima, Yoh, M.D, Honda, Kazuo, M.D, Hamada, Hirofumi, M.D, Kobayashi, Nobuaki, M.D

    Published in The Journal of surgical research (01-11-2009)
    “…Background The prognosis of bile duct cancer is quite poor because of the low resection rate and the tolerance of the cancer to chemotherapy and radiotherapy…”
    Get full text
    Journal Article
  2. 2

    Protective Effect of Adeno-Mediated Human Bcl-xL Gene Transfer to the Mouse Liver in a Partial Ischemia/Reperfusion Model by Honda, Kazuo, M.D, Tohyama, Taiji, M.D, Kotegawa, Hiroshi, M.D, Kojima, Yoh, M.D, Kushihata, Fumiki, M.D, Watanabe, Jota, M.D, Kobayashi, Nobuaki, M.D

    Published in The Journal of surgical research (01-11-2009)
    “…Background The protective effect of heat preconditioning has been ascribed to the induction of heat shock proteins (HSP) in the liver. We detected an increase…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain by Miyajima, Risa, Kawazoe, Hitoshi, Tsuneoka, Kikue, Fujiwara, Mitsuko, Kojima, Yoh, Yakushijin, Yoshihiro

    Published in Gan to kagaku ryoho (01-04-2013)
    “…Venous pain induced by oxaliplatin (L-OHP) is a clinical problem in relation to adherence in the CapeOX regimen. We investigated the preventive effect of…”
    Get more information
    Journal Article
  5. 5

    Two cases of advanced pancreas cancer treated with GTX: combined use of gemcitabine, docetaxel and capecitabine by Honda, Kazuo, Fukuhara, Toshiyuki, Kojima, Yoh, Tanaka, Hitoshi, Kushihata, Fumiki, Kobayashi, Nobuaki

    Published in Gan to kagaku ryoho (01-12-2006)
    “…Two cases of advanced pancreas cancer were treated with GTX. One cycle was 3 weeks, capecitabine (1,000 mg/m(2)/day) was administered from day 1 to 14, and GEM…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer by Kawazoe, Hitoshi, Shimasaki, Maya, Ueno, Masaki, Sumikawa, Satomi, Takatori, Shingo, Namba, Hiroyuki, Yoshida, Motohira, Sato, Koichi, Kojima, Yoh, Watanabe, Yuji, Moriguchi, Toshihide, Tanaka, Akihiro, Araki, Hiroaki

    Published in Journal of Cancer (01-01-2015)
    “…The aim of this study was to clarify the risk factors for discontinuing tegafur/gimeracil/oteracil potassium (S-1) adjuvant chemotherapy following gastrectomy…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Adenovirus-Mediated p53 Gene Transfer to the Bile Duct by Direct Administration Into the Bile in a Rat Cholangitis Model 1 by Kojima, Yoh, Honda, Kazuo, Kotegawa, Hiroshi, Kushihata, Fumiki, Kobayashi, Nobuaki, Liu, Bingbing, Yokoyama, Kazunari K.

    Published in The Journal of surgical research (2005)
    “…Hepatolithiasis is a common disease in East Asia and its aggravating factor is bile duct stenosis because of refractory cholangitis. This study investigated…”
    Get full text
    Journal Article
  10. 10

    Adenovirus-mediated p53 gene transfer to the bile duct by direct administration into the bile in a rat cholangitis model by KOJIMA, Yoh, HONDA, Kazuo, KOTEGAWA, Hiroshi, KUSHIHATA, Fumiki, KOBAYASHI, Nobuaki, BINGBING LIU, YOKOYAMA, Kazunari K

    Published in The Journal of surgical research (01-09-2005)
    “…Hepatolithiasis is a common disease in East Asia and its aggravating factor is bile duct stenosis because of refractory cholangitis. This study investigated…”
    Get full text
    Journal Article